Relay Therapeutics, Inc.

NasdaqGM:RLAY Stock Report

Mkt Cap: US$2.6b

Relay Therapeutics Financial Health

How is Relay Therapeutics's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: RLAY's short term assets ($1.1B) exceed its short term liabilities ($71.4M).

Long Term Liabilities: RLAY's short term assets ($1.1B) exceed its long term liabilities ($97.5M).


Debt to Equity History and Analysis

Debt Level: RLAY is debt free.

Reducing Debt: RLAY has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: RLAY has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: RLAY has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 36.8% each year


Discover healthy companies